The effect of fasting or desmopressin before treatment on the concentration of mitomycin C during intravesical administration

BJU International

Volumn 86, Issue 6, 2000, Pages 644-647

  Cliff, A M ^a,b   Heatherwick, B ^a   Scoble, J ^a   Parr, N J ^a  

^a WIRRAL UNIVERSITY TEACHING HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bladder; Mitomycin C; Pharmacokinetics; Transitional cell carcinoma

Indexed keywords

DESMOPRESSIN; DILUENT; MITOMYCIN C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG DEGRADATION; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESIDUAL URINE; TRANSITIONAL CELL CARCINOMA; URINE VOLUME;

ADMINISTRATION, INTRAVESICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; DESMOPRESSIN; FASTING; FEMALE; HUMAN; MALE; MITOMYCIN; RENAL AGENTS; URINE;

EID: 0033776420     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00869.x     Document Type: Article

References (9)

1. Tolley DA, Parmar MKB, Grigor KM et al. The effect of intravesical mitomycin Con recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol 1996; 155: 1233
2. Dalton JT, Wientjes MG, Badalament RA, Drago JR, Au JL. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer. Cancer Res 1991; 51: 5144-52
3. Gao X, Au JL, Badalament RA, Wientjes MG. Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Cancer Clin Res 1998; 3: 139-43
4. Wientjes MG, Badalament RA, Wang RC, Hassan F, Au JL. Penetration of mitomycin C in human bladder. Cancer Res 1993; 53: 3314-20
5. Wientjes MG, Badalament RA, Au JL. Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chemother Pharmacol 1993; 32: 255-62
6. Poston GJ, Joseph AEA, Riddle PR. The accuracy of ultrasound in the measurement of changes in bladder volume. Br J Urol 1983; 55: 361-3
7. Thrasher JB, Crawford ED. Complications of intravesical chemotherapy. Urol Clin N Am 1992; 19: 529-39
8. Vilhardt H, Lundin S. Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen Pharmacol 1986; 17: 481-3
9. Badalament RA, Farah RN. Treatment of superficial bladder cancer with intravesical chemotherapy. Sem Surg Oncol 1997; 13: 335-41